- Home
- NBTX vs BWAY Comparison
NBTX vs BWAY Comparison
Compare NBTX & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- BWAY
- Stock Information
- Founded
- NBTX 2003
- BWAY 2003
- Country
- NBTX France
- BWAY Israel
- Employees
- NBTX N/A
- BWAY N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- BWAY Medical/Dental Instruments
- Sector
- NBTX Health Care
- BWAY Health Care
- Exchange
- NBTX Nasdaq
- BWAY Nasdaq
- Market Cap
- NBTX 167.8M
- BWAY 201.1M
- IPO Year
- NBTX 2020
- BWAY 2019
- Fundamental
- Price
- NBTX $4.48
- BWAY $10.96
- Analyst Decision
- NBTX Strong Buy
- BWAY Strong Buy
- Analyst Count
- NBTX 1
- BWAY 2
- Target Price
- NBTX $8.00
- BWAY $14.25
- AVG Volume (30 Days)
- NBTX 9.0K
- BWAY 33.0K
- Earning Date
- NBTX 04-02-2025
- BWAY 08-05-2025
- Dividend Yield
- NBTX N/A
- BWAY N/A
- EPS Growth
- NBTX N/A
- BWAY N/A
- EPS
- NBTX N/A
- BWAY 0.08
- Revenue
- NBTX N/A
- BWAY $43,457,000.00
- Revenue This Year
- NBTX N/A
- BWAY $351.53
- Revenue Next Year
- NBTX $221.06
- BWAY $21.84
- P/E Ratio
- NBTX N/A
- BWAY $54.48
- Revenue Growth
- NBTX N/A
- BWAY 26.86
- 52 Week Low
- NBTX $2.76
- BWAY $5.67
- 52 Week High
- NBTX $6.00
- BWAY $12.00
- Technical
- Relative Strength Index (RSI)
- NBTX 51.68
- BWAY 58.38
- Support Level
- NBTX $4.18
- BWAY $10.81
- Resistance Level
- NBTX $5.76
- BWAY $11.40
- Average True Range (ATR)
- NBTX 0.24
- BWAY 0.46
- MACD
- NBTX -0.06
- BWAY -0.03
- Stochastic Oscillator
- NBTX 21.69
- BWAY 50.88
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.